The global nutraceutical CDMO market is on a trajectory of impressive growth, with a projected year-over-year increase of 6.8%. According to recent forecasts, the market, valued at USD 35,730.8 million in 2024, is set to surge to USD 61,655.3 million by 2034. This robust expansion is underpinned by a compound annual growth rate (CAGR) of 5.6% over the forecast period.

The global molecular imaging market is witnessing a significant surge, driven by the escalating demand for advanced diagnostic technologies. According to a recent market analysis, the industry is projected to grow at an impressive compound annual growth rate (CAGR) of 11.0% over the next decade. In 2023, the market achieved a remarkable valuation of USD 5,437.2 million, and this upward trajectory is expected to continue, with projections indicating a market size of USD 15,457.48 million by 2033.

The global veterinary biologics market is projected to witness robust growth, reaching a valuation of USD 13,140.6 million in 2024 and soaring to an estimated USD 24,224.3 million by 2034. This growth is underpinned by a promising compound annual growth rate (CAGR) of 6.3% over the forecast period from 2024 to 2034.

The global protein A resins market, valued at USD 677.84 million in 2023, is anticipated to almost double in size, reaching approximately USD 1,477.01 million by 2033. This impressive growth reflects a compound annual growth rate (CAGR) of 8.1%, fueled by rising demand for protein purification processes across sectors like biotechnology, pharmaceuticals, and diagnostics.

The global pharmacy automation market is on the brink of a transformative leap, projected to grow from USD 6.1 billion in 2023 to an impressive USD 13.3 billion by 2033. This rapid expansion is expected to achieve a robust compound annual growth rate (CAGR) of 8.1% over the forecast period, underscoring the sector’s dynamic evolution.